Zeiher, A.M.

patient level cd 40 ligand serum syndrome study follow-up infarction event group -10 ligand month factor trial troponin value angina placebo circulation treatment growth tranilast restenosi troponin t marker death outcome plgf levels nonfatal hazard figure protein mpo serum levels abciximab disease 6 months 30 days 6- month follow-up hazard ratio baseline ratio c-reactive protein heart chest pain il -10 result artery disease scd 40l c-reactive quintile stent lesion quartile analysis heeschen model percent hgf serum levels hgf levels liter platelet angiographic placental growth factor table difference activation effect point vegf serum levels artery threshold chest evidence vessel prognostic vegf levels target threshold level placebo group